Lapatinib In Combination With Chemotherapy In Subjects With Relapsed Breast Cancer
Status: TERMINATED
Study type: INTERVENTIONAL
Conditions: Relapsed Breast Cancer|Neoplasms, Breast
Interventions: DRUG: Lapatinib|DRUG: Capecitabine|DRUG: Docetaxel|DRUG: nab-Paclitaxel
Sponsor: GlaxoSmithKline